Lipid overload and overflow: Metabolic trauma and the metabolic syndrome

Trends in Endocrinology and Metabolism

Volumn 14, Issue 9, 2003, Pages 398-403

  Unger, Roger H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN;

ADIPOCYTE; FAT INTAKE; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HORMONE RESISTANCE; HUMAN; HYPOLEPTINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEPTIN RESISTANCE; LIPID METABOLISM; LIPID OVERLOAD; LIPOGENESIS; METABOLIC DISORDER; METABOLIC SYNDROME X; METABOLIC TRAUMA; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTECTION; REVIEW; UNITED STATES;

EID: 0242696221     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2003.09.008     Document Type: Article

References (52)

1. Reaven, G.M. (1991) Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia and coronary heart disease. Am. Heart J. 121, 1283-1288
2. Ford, E.S. et al. (2002) Prevalence of the metabolic syndrome among U.S. adults: findings from the third National Health and Nutrition Examination survey. J. Am. Med. Assoc. 287, 356-359
3. Quon, M.J. et al. (1994) Insulin receptor substrate 1 mediates the stimulatory effect of insulin on GLUT4 translocation in transfected rat adipose cells. J. Biol. Chem. 269, 27920-27924
4. McGarry, J.D. et al. (1977) A possible role for malonyl CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Invest. 60, 265-270
5. Shimomura, I. et al. (1999) Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin induced diabetes. Proc. Natl. Acad. Sci. U. S. A. 96, 13656-13661
6. Foufelle, F. and Ferré, P. (2002) New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor SREBP-1c. Biochem. J. 366, 377-391
7. Kakuma, T. et al. (2000) Leptin, troglitazone and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc. Natl. Acad. Sci. U. S. A. 97, 8536-8541
8. Boden, G. and Shulman, G.I. (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. J. Clin. Invest. 32 (Suppl. 3), 14-23
9. Shimomura, I. et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77-86
10. White, M.F. (1998) The IRS-signaling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182, 3-21
11. Virkamaki, B. et al. (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103, 931-943
12. Summers, S.A. et al. (1998) Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 18, 5457-5464
13. Shulman, G.I. (2000) Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171-176
14. Kim, Y-B. et al. (2002) Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda/zeta but not on glycogen synthase kinase-3. J. Biol. Chem. 277, 32915-32933
15. Tobe, K. et al. (2001) Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2 -/- mouse liver. J. Biol. Chem. 276, 38337-38340
16. Shimomura, I. et al. (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401, 73-76
17. Shimomura, I. et al. (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274, 30028-30032
18. Muller-Wieland, D. and Kotzka, J. (2002) SREBP-1: gene regulatory key to syndrome X? Ann. N. Y. Acad. Sci. 967, 19-27
19. Lee, Y. et al. (2001) Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 276, 5629-5635
20. Unger, R.H. et al. (1999) Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc. Natl. Acad. Sci. U. S. A. 96, 2327-2332
21. Lee, Y. et al. (1994) β-cell lipotoxicity in the pathogenesis of noninsulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc. Natl. Acad. Sci. U. S. A. 91, 10878-10882
22. Zhou, Y.T. et al. (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U. S. A. 97, 1784-1789
23. Koyama, K. et al. (1997) Tissue triglycerides, insulin resistance and insulin production: implications for hyperinsulinemia of obesity. Am. J. Physiol. 273, E708-E713
24. Sinha, R. et al. (2002) Assessment of skeletal muscle triglyceride content by (1) H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat and central adiposity. Diabetes 51, 1022-1027
25. Scevola, D. et al. (2000) Reversal of cachexia in patients treated with potent antiretroviral therapy. AIDS Read. 10, 365-375
26. Szczepaniak, L.S. et al. (2003) Myocardial triglycerides and systematic function in humans: in vivo evaluation by localized protein spectroscopy and cardiac imagining. Magn. Reson. Med. 49, 417-423
27. Oral, E.A. et al. (2002) Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346, 570-578
28. Minokoshi, Y. and Kahn, B.B. (2003) Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem. Soc. Trans Rans. 31, 196-201
29. Seip, M. and Trygstad, O. (1996) Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl. 413, 2-28
30. Zhang, Y. et al. (2002) Determinants of leptin gene expression in fat depots of lean mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R226-R234
31. Tsao, T.S. et al. (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol. 440, 213-221
32. Fruebis, J. et al. (2001) Proteolytic cleavage product of 30 kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 98, 2005-2010
33. Tomas, E. et al. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U. S. A. 99, 16309-16313
34. Addy, C.L. et al. (2003) Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia virus-infected patients treated with highly active antiretroviral therapy. J. Clin. Endocrinol. Metab. 88, 627-636
35. Thamer, C. et al. (2002) Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm. Metab. Res. 34, 646-649
36. Lindsay, R.S. et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360, 57-58
37. Combs, T.P. et al. (2002) Induction of adipocyte complement-related protein of kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization. Endocrinology 143, 998-1007
38. Shimabukuro, M. et al. (1998) Lipoapoptosis in β-cells of obese prediabetic fa/fa rats: role of serine palmitoyltransferase overexpression. J. Biol. Chem. 273, 32487-32490
39. Chiu, H.C. et al. (2001) A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107, 813-822
40. Datta, S.R. et al. (1997) Akt phosphorylation of BAD couples survival signal to the cell intrinsic death machinery. Cell 91, 231-241
41. Bjorbak, C. et al. (2000) SOCS-3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649-40657
42. Zabolotny, J.M. et al. (2002) PTP-1B regulates leptin signal transduction in vivo. Dev. Cell 2, 489-495
43. Chen, G.A. et al. (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase IB. Dev. Cell 2, 497-503
44. Goldstein, B.J. et al. (1998) Regulation of the insulin-signaling pathway by cellular protein-tyrosine phosphatases. Mol. Cell. Biochem. 182, 91-99
45. Masuzaki, H. et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170
46. Chung, C.D. et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805
47. Li, C. and Friedman, J.M. (1999) Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc. Natl. Acad. Sci. U. S. A. 96, 9677-9682
48. Kotelevisev, Y.V. et al. (1997) 11-β-hydroxysteroid dehydrogenase type I knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycemia on obesity and stress. Proc. Natl. Acad. Sci. U. S. A. 94, 14924-14929
49. Livingstone, D.E.W. et al. (2000) Understanding the role of glucocorticoids in obesity: tissue specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141, 560-563
50. Veldman, R.G. et al. (2001) Hyperleptinemia in women with Cushing's disease is driven by high-amplitude pulsatile, but orderly and eurhythmic, leptin secretion. Eur. J. Endocrinol. 144, 21-27
51. Minocci, A. et al. (2000) Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int. J. Obes. Relat. Metab. Disord. 24, 1139-1144
52. Zimmet, P. et al. (1999) Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann. N. Y. Acad. Sci. 892, 25-44